Detalhe da pesquisa
1.
Structural Repertoire of HIV-1-Neutralizing Antibodies Targeting the CD4 Supersite in 14 Donors.
Cell
; 161(6): 1280-92, 2015 Jun 04.
Artigo
Inglês
| MEDLINE | ID: mdl-26004070
2.
Discovery of Potent Pyrazoline-Based Covalent SARS-CoV-2 Main Protease Inhibitors.
Chembiochem
; 24(11): e202300116, 2023 06 01.
Artigo
Inglês
| MEDLINE | ID: mdl-37069799
3.
Multidonor analysis reveals structural elements, genetic determinants, and maturation pathway for HIV-1 neutralization by VRC01-class antibodies.
Immunity
; 39(2): 245-58, 2013 Aug 22.
Artigo
Inglês
| MEDLINE | ID: mdl-23911655
4.
The Epstein-Barr Virus Episome Maneuvers between Nuclear Chromatin Compartments during Reactivation.
J Virol
; 92(3)2018 02 01.
Artigo
Inglês
| MEDLINE | ID: mdl-29142137
5.
Co-evolution of a broadly neutralizing HIV-1 antibody and founder virus.
Nature
; 496(7446): 469-76, 2013 Apr 25.
Artigo
Inglês
| MEDLINE | ID: mdl-23552890
6.
Bromodomain and extraterminal inhibitors block the Epstein-Barr virus lytic cycle at two distinct steps.
J Biol Chem
; 292(32): 13284-13295, 2017 08 11.
Artigo
Inglês
| MEDLINE | ID: mdl-28588024
7.
Structure of HIV-1 gp120 V1/V2 domain with broadly neutralizing antibody PG9.
Nature
; 480(7377): 336-43, 2011 Nov 23.
Artigo
Inglês
| MEDLINE | ID: mdl-22113616
8.
Outer domain of HIV-1 gp120: antigenic optimization, structural malleability, and crystal structure with antibody VRC-PG04.
J Virol
; 87(4): 2294-306, 2013 Feb.
Artigo
Inglês
| MEDLINE | ID: mdl-23236069
9.
Contributions of Hyperactive Mutations in Mpro from SARS-CoV-2 to Drug Resistance.
ACS Infect Dis
; 10(4): 1174-1184, 2024 Apr 12.
Artigo
Inglês
| MEDLINE | ID: mdl-38472113
10.
PGV04, an HIV-1 gp120 CD4 binding site antibody, is broad and potent in neutralization but does not induce conformational changes characteristic of CD4.
J Virol
; 86(8): 4394-403, 2012 Apr.
Artigo
Inglês
| MEDLINE | ID: mdl-22345481
11.
Crystal Structures of Inhibitor-Bound Main Protease from Delta- and Gamma-Coronaviruses.
Viruses
; 15(3)2023 03 18.
Artigo
Inglês
| MEDLINE | ID: mdl-36992489
12.
Systematic Analyses of the Resistance Potential of Drugs Targeting SARS-CoV-2 Main Protease.
ACS Infect Dis
; 9(7): 1372-1386, 2023 07 14.
Artigo
Inglês
| MEDLINE | ID: mdl-37390404
13.
Comprehensive fitness landscape of SARS-CoV-2 Mpro reveals insights into viral resistance mechanisms.
Elife
; 112022 06 20.
Artigo
Inglês
| MEDLINE | ID: mdl-35723575
14.
Defining the substrate envelope of SARS-CoV-2 main protease to predict and avoid drug resistance.
Nat Commun
; 13(1): 3556, 2022 06 21.
Artigo
Inglês
| MEDLINE | ID: mdl-35729165
15.
NITD-688, a pan-serotype inhibitor of the dengue virus NS4B protein, shows favorable pharmacokinetics and efficacy in preclinical animal models.
Sci Transl Med
; 13(579)2021 02 03.
Artigo
Inglês
| MEDLINE | ID: mdl-33536278
16.
PARP1 restricts Epstein Barr Virus lytic reactivation by binding the BZLF1 promoter.
Virology
; 507: 220-230, 2017 07.
Artigo
Inglês
| MEDLINE | ID: mdl-28456021
17.
Somatic Hypermutation-Induced Changes in the Structure and Dynamics of HIV-1 Broadly Neutralizing Antibodies.
Structure
; 24(8): 1346-1357, 2016 08 02.
Artigo
Inglês
| MEDLINE | ID: mdl-27477385
18.
Delineating antibody recognition in polyclonal sera from patterns of HIV-1 isolate neutralization.
Science
; 340(6133): 751-6, 2013 May 10.
Artigo
Inglês
| MEDLINE | ID: mdl-23661761